The Brain Structure and Neural Network Changing the Before and After Ventriculo-peritoneal Shunting in the Normal Pressure Hydrocephalus Patients

March 22, 2017 updated by: Peking Union Medical College Hospital
With the advent of the aging society, dementia becomes the focus of common people. As for the neurodegeneration dementia, no disease modifying treatments have been discovered. Idiopathic normal pressure hydrocephalus (iNPH) is considered as one of reversible dementia, which can be hint by the surgery. In addition, dementia of iNPH is the typical subcortical dementia. Therefore exploring the pathogenic mechanism is conducive to the early diagnosis and treatment. This research is to monitor the changing of iNPHGS, cognitive function, walking ability as well as brain construction imaging and neural network before and after ventriculo-peritoneal shunting in order to demonstrate the pathogenesis of triads. In the process, the supplementary test, for instance, CSF tap test, will be validated the predictive value.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100730
        • Recruiting
        • Peking Union Medical College Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • Jing Gao, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with physical and cognitive symptoms and brain image findings (Brain CT or MRI) suggestive of NPH were evaluated at neurological outpatient clinic of Peking Union Medical College Hospital according to the NPH diagnosis criteria.

Description

Inclusion Criteria:

ncluded will be subjects with a probable diagnosis of NPH. The diagnosis will be based primarily on presence of gait impairment plus at least one other impairment in urinary symptoms, cognition impairment or both.

  1. Are 50 years old or older
  2. Patients who understand the study protocol
  3. Patients who meet the criteria for NPH

    1. A typical personal history
    2. A typical brain imaging on head CT or MRI
    3. Normal LP findings excluding other conditions
    4. Exclusion of other conditions causing the symptomatology

Exclusion Criteria:

  1. Patients below the age of 50 years.
  2. Patients who underwent shunt surgery before

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
normal pressure hydrocephalus

Included will be subjects with a probable diagnosis of NPH. The diagnosis will be based primarily on presence of gait impairment plus at least one other impairment in urinary symptoms, cognition impairment or both

The NPH patients will undergo the CSF tap test and then receive the ventriculo-peritoneal shunting surgery. They will have the examination of brain constructure neuroimaging and functional MRI prior to and posterior to the shunting.

A mainstream therapy for NPH. It involves the device of CSF flow control of shunts and accessories(CFDA(I)20143665605)
normal control
Healthy volunteers will undergo the examination of brain constructure and functional MRI.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The brain constructure and neural network changing one day after shunting
Time Frame: Day 1 after shunting
  • Using the voxel based morphology technique to measure the ventricular volume and brain lobe volume
  • Neural network( DMN)by the resting functional MRI
Day 1 after shunting
The brain constructure and neural network changing 90 days after shunting
Time Frame: Day 90 after shunting

Using the voxel based morphology technique to measure the ventricular volume and brain lobe volume

•Neural network( DMN)by the resting functional MRI

Day 90 after shunting
The brain constructure and neural network changing one year after shunting
Time Frame: one year after shunting

Using the voxel based morphology technique to measure the ventricular volume and brain lobe volume

•Neural network( DMN)by the resting functional MRI

one year after shunting

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the clinical syndrome of normal pressure hydrocephalus
Time Frame: Day 1 after shunting
iNPHGS
Day 1 after shunting
Assessment of the clinical syndrome of normal pressure hydrocephalus
Time Frame: Day 90 after shunting
iNPHGS
Day 90 after shunting
Assessment of the clinical syndrome of normal pressure hydrocephalus
Time Frame: one year after shunting
iNPHGS
one year after shunting

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognition assessments
Time Frame: Day 1 after shunting
The neuropsychological battery assessment (including MMSE, MOCA as well as cognitive domains especially executive function examinations)
Day 1 after shunting
Cognition assessments
Time Frame: Day 90 after shunting
The neuropsychological battery assessment (including MMSE, MOCA as well as cognitive domains especially executive function examinations)
Day 90 after shunting
Cognition assessments
Time Frame: one year after shunting
The neuropsychological battery assessment (including MMSE, MOCA as well as cognitive domains especially executive function examinations)
one year after shunting
Walking ability evaluation
Time Frame: Day 1 after shunting
Including 10m walking test, up and go tests
Day 1 after shunting
Walking ability evaluation
Time Frame: Day 90 after shunting
Including 10m walking test, up and go tests
Day 90 after shunting
Walking ability evaluation
Time Frame: one year after shunting
Including 10m walking test, up and go tests
one year after shunting

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jing Gao, MD, Department of Neurology, Peking Union Medical College Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Anticipated)

August 1, 2018

Study Completion (Anticipated)

August 1, 2019

Study Registration Dates

First Submitted

March 22, 2017

First Submitted That Met QC Criteria

March 22, 2017

First Posted (Actual)

March 28, 2017

Study Record Updates

Last Update Posted (Actual)

March 28, 2017

Last Update Submitted That Met QC Criteria

March 22, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Normal Pressure Hydrocephalus

Clinical Trials on ventriculo-peritoneal shunting

Subscribe